Skip to main content

Table 3 Number of estimated new cases, overall and per case lifetime burden (Belgium, 2011)

From: The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease

 

Estimated number of new cases in 2011 (95% CrI)

DALY (95% CrI)

DALY per case (95% CrI)

Haemophilia (total)

14 (7–22)

145 (90–222)

11 (8–15)

 Severe

6 (3–10)

98 (43–175)

17 (13–20)

 Moderate

3 (1–5)

29 (27–31)

12 (5–25)

 Mild

5 (2–8)

18 (17–20)

4 (2–9)

Haemophilia A

11 (5–18)

123 (74–193)

11 (8–16)

 Severe

5 (2–9)

86 (37–156)

17 (13–20)

 Moderate

2 (1–4)

22 (20–23)

12 (5–28)

 Mild

4 (2–7)

15 (14–17)

5 (2–10)

Haemophilia B

2 (1–5)

22 (12–42)

10 (5–18)

 Severe

1 (0–2)

12 (2–32)

17 (13–20)

 Moderate

1 (0–2)

7 (6–8)

16 (4–55)

 Mild

1 (0–2)

3 (2–3)

4 (1–13)

  1. 95% CrI: 95% credible interval.
  2. Number of estimated new haemophilia cases, overall lifetime haemophilia burden and lifetime haemophilia burden per case per haemophilia type and severity in Belgium in 2011.